HCWB

HCW Biologics Inc. [HCWB] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

HCWB Stock Summary

Top HCWB Correlated Resources

HCWB


Top 10 Correlated ETFs

HCWB


Top 10 Correlated Stocks

HCWB


In the News

09:22 28 Mar 2024 HCWB

HCW Biologics Inc (HCWB), Quotient Technology (QUOT) – Smith Micro Software And 3 Other Stocks Under $3 Insiders Are Aggressively Buying

US crude oil futures traded lower this morning on Wednesday. Investors, meanwhile, focused on some notable insider trades.

08:00 28 Mar 2024 HCWB

HCW Biologics to Present at 2022 Virtual Growth Conference Sponsored by the Maxim Group and M-Vest

Founder and CEO, Hing C. Wong, Ph.D., to be guest at “Fireside Chat” Founder and CEO, Hing C. Wong, Ph.D., to be guest at “Fireside Chat”

09:22 28 Mar 2024 HCWB

Masonic Cancer Center To Evaluate HCW Biologics' Bifunctional Fusion Protein In Advanced Cancers

The FDA cleared the Masonic Cancer Center, University of Minnesota to evaluate HCW Biologics Inc's (NASDAQ: HCWB) lead drug candidate, HCW9218, in Phase 1 trial in patients with advanced solid tumors with progressive disease after prior chemotherapies.  HCW9218 is an injectable, bifunctional fusion protein complex designed to drive anti-tumor activity by activating desired immune responses to attack cancer cells while simultaneously blocking unwanted immunosuppressive activities.

09:24 28 Mar 2024 HCWB

HCW Biologics Lead Candidate Shows Preclinical Anti-Tumor Activity, Reduced Side Effects of Chemo

HCW Biologics Inc (NASDAQ: HCWB) has announced the publication of a scientific paper in Molecular Therapy highlighting preclinical data of its lead program, HCW9218. The preclinical data demonstrated that HCW9218 enhanced the anti-tumor efficacy of chemotherapy drugs and diminished their harmful side effects by reducing therapy-induced senescence (TIS).

01:17 28 Mar 2024 HCWB

Good Penny Stocks to Buy Right Now? 3 to Watch in November

Are these penny stocks worth buying right now? The post Good Penny Stocks to Buy Right Now?

12:37 28 Mar 2024 HCWB

Making a Penny Stocks Watchlist? Don't Forget These 3 Small-Caps

Three penny stocks that could be worth watching in the second half of October The post Making a Penny Stocks Watchlist? Don't Forget These 3 Small-Caps appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

07:32 28 Mar 2024 HCWB

HCW Biologics Showcases Scientific Paper in Molecular Therapy Highlighting Potential of HCW9218 as Novel, Bifunctional Cancer Immunotherapeutic

Lead Drug Candidate Engineered Using Tissue FactOr-Based FusIon (TOBI™) Platform

07:32 28 Mar 2024 HCWB

HCW Biologics' Article Published in Cancer Immunology Research Validates Novel Tissue Factor Scaffold Fusion Protein (TOBI™) Discovery Platform

TOBI™ Discovery Platform Creates GMP-Scale Heteromeric Fusion Protein Complexes (HFPCs) That Solve Issues with Multi-Signal Receptor Engagement on Immune Cells

07:10 28 Mar 2024 HCWB

HCW Biologics Reports Second Quarter Financial Results and Recent Business Highlights

MIRAMAR, Fla., Aug. 13, 2021 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company”) (NASDAQ: HCWB), an innovative, biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation and age-related diseases, today reported financial results and recent business highlights for its second quarter ended June 30, 2021.

04:05 28 Mar 2024 HCWB

HCW Biologics Inc. Announces Closing of $56.0 Million Initial Public Offering

MIRAMAR, Fla., July 22, 2021 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (NASDAQ:HCWB) (the "Company"), an innovative preclinical stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation and age-related diseases, today announced the closing of its previously announced underwritten initial public offering of 7,000,000 shares of common stock at a public offering price of $8.00 per share for gross proceeds of $56.0 million, prior to deducting underwriting discounts, commissions, and other offering expenses. All of the shares of common stock were offered by the Company. The shares began trading on the Nasdaq Global Market on July 20, 2021, under the ticker symbol “HCWB.” In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 1,050,000 shares at the public offering price less the underwriting discounts and commissions.

HCWB Financial details

Company Rating
Neutral
Market Cap
62.96M
Income
-19.46M
Revenue
2.86M
Book val./share
0.66
Cash/share
0.31
Dividend
-
Dividend %
-
Employees
44
Optionable
No
Shortable
Yes
Earnings
27 Mar 2024
P/E
-2.1
Forward P/E
-3.19
PEG
1.26
P/S
14.34
P/B
1.72
P/C
5.55
P/FCF
-1.64
Quick Ratio
2.2
Current Ratio
2.56
Debt / Equity
0.27
LT Debt / Equity
0.27
-
-
EPS (TTM)
-0.55
EPS next Y
-0.54
EPS next Q
1.58
EPS this Y
-37.88%
EPS next Y
-1.82%
EPS next 5Y
-64.55%
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
36.98%
EPS Q/Q
16.67%
-
-
-
-
SMA20
100%
SMA50
100%
SMA100
-
Inst Own
2.17%
Inst Trans
0.78%
ROA
-55%
ROE
-64%
ROC
-0.68%
Gross Margin
20%
Oper. Margin
-721%
Profit Margin
-681%
Payout
-
Shs Outstand
35.97M
Shs Float
16M
-
-
-
-
Target Price
-
52W Range
0.91-2.32
52W High
-
52W Low
-
RSI
62
Rel Volume
0.13
Avg Volume
17.33K
Volume
2.17K
Perf Week
1.18%
Perf Month
50.88%
Perf Quarter
-19.63%
Perf Half Y
-12.69%
-
-
-
-
Beta
0.924
-
-
Volatility
0.02%, 0.2%
Prev Close
-2.27%
Price
1.72
Change
5.52%

HCWB Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K
Revenue per share
00.1400.19
Net income per share
-0.3-0.2-0.66-0.41
Operating cash flow per share
-0.28-0.36-0.58-0.29
Free cash flow per share
-0.34-0.37-0.59-0.58
Cash per share
0.30.31.960.9
Book value per share
0.370.52.731.04
Tangible book value per share
0.370.52.731.04
Share holders equity per share
0.370.52.731.04
Interest debt per share
00.02-0.10.18
Market cap
153.9M180.23M43.55M68.59M
Enterprise value
146.54M172.34M31.82M52.68M
P/E ratio
-21.31-31.18-3.52-4.66
Price to sales ratio
043.96010.2
POCF ratio
-22.75-17.28-3.97-6.6
PFCF ratio
-18.71-16.97-3.95-3.32
P/B Ratio
17.112.520.851.83
PTB ratio
17.112.520.851.83
EV to sales
042.0407.84
Enterprise value over EBITDA
-21.11-32.96-2.48-3.57
EV to operating cash flow
-21.66-16.52-2.9-5.07
EV to free cash flow
-17.82-16.23-2.89-2.55
Earnings yield
-0.05-0.03-0.28-0.21
Free cash flow yield
-0.05-0.06-0.25-0.3
Debt to equity
00.04-0.040.17
Debt to assets
00.04-0.030.14
Net debt to EBITDA
1.061.510.911.08
Current ratio
7.5312.1417.4411.52
Interest coverage
000-119.05
Income quality
0.931.80.850.7
Dividend Yield
000.060
Payout ratio
00-0.230
Sales general and administrative to revenue
00.5901.24
Research and developement to revenue
01.7701.39
Intangibles to total assets
0000
Capex to operating cash flow
0.220.0200.99
Capex to revenue
0-0.050-1.53
Capex to depreciation
-3.46-0.31-0.09-14.31
Stock based compensation to revenue
00.0100.17
Graham number
1.571.516.363.11
ROIC
-0.81-0.39-0.26-0.34
Return on tangible assets
-0.72-0.38-0.23-0.31
Graham Net
0.260.341.90.66
Working capital
6.96M11.15M38.16M31.11M
Tangible asset value
9M14.4M51.19M37.43M
Net current asset value
6.96M11.15M38.16M24.69M
Invested capital
00.04-0.040.17
Average receivables
01.25M1.32M275.35K
Average payables
0273.84K189.5K724.91K
Average inventory
0269.15K1.37M1.8M
Days sales outstanding
0222.57022.68
Days payables outstanding
339.490150.18108.22
Days of inventory on hand
001.47K123.11
Receivables turnover
01.64016.09
Payables turnover
1.0802.433.37
Inventory turnover
000.252.96
ROE
-0.8-0.4-0.24-0.39
Capex per share
-0.06-0.010-0.29

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.050.0400.020.02
Net income per share
-0.11-0.15-0.14-0.12-0.14
Operating cash flow per share
-0.06-0.11-0.1-0.26-0.16
Free cash flow per share
-0.35-0.11-0.11-0.3-0.17
Cash per share
0.730.890.790.480.31
Book value per share
1.191.040.910.80.66
Tangible book value per share
1.191.040.910.80.66
Share holders equity per share
1.191.040.910.80.66
Interest debt per share
0.180.180.180.180.18
Market cap
82.06M68.67M50.27M77.93M68.26M
Enterprise value
62.29M52.75M38.27M76.84M63.37M
P/E ratio
-5.39-3.21-2.58-4.53-3.46
Price to sales ratio
45.3651.191.2K125.1280.02
POCF ratio
-35.45-18.12-13.82-8.3-12.21
PFCF ratio
-6.57-17.8-12.76-7.12-10.98
P/B Ratio
1.931.831.542.732.86
PTB ratio
1.931.831.542.732.86
EV to sales
34.4339.32913.73123.3774.29
Enterprise value over EBITDA
-16.16-9.31-7.69-19.58-13.88
EV to operating cash flow
-26.91-13.92-10.52-8.18-11.34
EV to free cash flow
-4.99-13.67-9.72-7.02-10.19
Earnings yield
-0.05-0.08-0.1-0.06-0.07
Free cash flow yield
-0.15-0.06-0.08-0.14-0.09
Debt to equity
0.150.170.20.220.27
Debt to assets
0.130.140.150.160.18
Net debt to EBITDA
5.132.812.410.281.07
Current ratio
12.5211.526.624.362.56
Interest coverage
-38.12-267.34-57.37-47.22-53.16
Income quality
0.590.70.722.181.13
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.942.2474.434.744.13
Research and developement to revenue
1.462.1853.862.61.95
Intangibles to total assets
00000
Capex to operating cash flow
4.390.020.080.170.11
Capex to revenue
-5.62-0.05-7.17-2.5-0.74
Capex to depreciation
-61.89-0.26-1.01-5.47-2.27
Stock based compensation to revenue
0.170.216.190.420.26
Graham number
1.691.871.671.471.43
ROIC
-0.08-0.13-0.13-0.14-0.18
Return on tangible assets
-0.07-0.11-0.11-0.11-0.14
Graham Net
0.520.660.50.210.02
Working capital
26.41M31.11M25.42M15.26M8.43M
Tangible asset value
42.56M37.43M32.62M28.59M23.87M
Net current asset value
19.91M24.69M19.02M8.9M2.1M
Invested capital
0.150.170.20.220.27
Average receivables
351.24K386.63K335.21K479.97K708.64K
Average payables
853.28K1.32M1.2M1.64M2.64M
Average inventory
1.66M1.66M1.26M1.24M1.55M
Days sales outstanding
17.6928.02543.07102.274.91
Days payables outstanding
87.71102.833.57K379.1418.45
Days of inventory on hand
119.53116.983.47K243.01231.17
Receivables turnover
5.093.210.170.881.2
Payables turnover
1.030.880.030.240.22
Inventory turnover
0.750.770.030.370.39
ROE
-0.09-0.14-0.15-0.15-0.21
Capex per share
-0.280-0.01-0.04-0.02

HCWB Frequently Asked Questions

What is HCW Biologics Inc. stock symbol ?

HCW Biologics Inc. is a US stock , located in Miramar of Fl and trading under the symbol HCWB

What is HCW Biologics Inc. stock quote today ?

HCW Biologics Inc. stock price is $1.72 today.

Is HCW Biologics Inc. stock public?

Yes, HCW Biologics Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap